Fenimore Asset Management’s AngioDynamics ANGO Stock Holding History

Fenimore Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-571,900	Closed	-$10.5M	–	116
2019 Q3	$10.5M	Buy	571,900 +800	+0.1%	+$15.6K	0.35%	62
2019 Q2	$11.2M	Buy	571,100 +2,800	+0.5%	+$57K	0.37%	57
2019 Q1	$13M	Hold	568,300	–	–	0.47%	48
2018 Q4	$11.4M	Sell	568,300 -100	-0%	-$2.07K	0.46%	52
2018 Q3	$12.4M	Buy	568,400 +1,130	+0.2%	+$25.1K	0.43%	51
2018 Q2	$12.6M	Sell	567,270 -41,135	-7%	-$841K	0.48%	50
2018 Q1	$10.5M	Buy	608,405 +13,915	+2%	+$232K	0.41%	55
2017 Q4	$9.89M	Buy	594,490 +3,715	+0.6%	+$63.4K	0.38%	57
2017 Q3	$10.1M	Buy	590,775 +11,550	+2%	+$194K	0.41%	55
2017 Q2	$9.39M	Buy	579,225 +48,150	+9%	+$761K	0.39%	55
2017 Q1	$9.21M	Buy	+531,075	New	+$8.88M	0.39%	57

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fenimore Asset Management's ANGO Position: Q4 2019 in Review

Fenimore Asset Management sold out of AngioDynamics (ANGO) in Q4 2019, closing a stake of 571,900 shares — an estimated $10.5M sold.

Fenimore Asset Management first reported a position in ANGO in Q1 2017 and held it in 11 quarters. The position peaked at $13M in Q1 2019. 157 funds tracked by Wall St. Rank hold ANGO as of Q4 2019.

Fenimore Asset Management reported no remaining AngioDynamics position as of Q4 2019 after selling out during the quarter.
Fenimore Asset Management sold 571,900 AngioDynamics shares in Q4 2019, an estimated $10.5M.
Fenimore Asset Management first reported a position in AngioDynamics in Q1 2017 and held it in 11 quarters.
Fenimore Asset Management's AngioDynamics position peaked at $13M in Q1 2019.
157 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2019.

Based on Fenimore Asset Management's 13F filing for Q4 2019, filed 16 Jan 2020.